Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Industry
|
| gptkbp:focusesOn |
Over-the-counter products
|
| gptkbp:hasCharacter |
Personalized medicine
Sustainability initiatives Natural products E-commerce growth Digital_health_solutions |
| gptkbp:hasCitations |
Regulatory compliance
Market competition Consumer trust Economic downturns Product recalls Supply chain issues Changing consumer preferences Technological disruptions Pricing pressures |
| gptkbp:hasMajorCity |
gptkb:GlaxoSmithKline
gptkb:Johnson_&_Johnson gptkb:Reckitt_Benckiser gptkb:Procter_&_Gamble gptkb:Abbott_Laboratories gptkb:Pfizer gptkb:Merck_&_Co. gptkb:Bayer Novartis Sanofi |
| https://www.w3.org/2000/01/rdf-schema#label |
Consumer Healthcare
|
| gptkbp:includes |
Allergy medications
Skin care products Oral care products Pain relief medications Vitamins and supplements First aid products Digestive health products Cold and flu remedies Weight_management_products |
| gptkbp:isCharacterizedBy |
Brand loyalty
Marketing strategies Distribution channels Product innovation |
| gptkbp:isInfluencedBy |
Technological advancements
Consumer trends Aging population Health awareness |
| gptkbp:isMarketedAs |
General public
|
| gptkbp:isPartOf |
Pharmaceutical industry
|
| gptkbp:isRegulatedBy |
gptkb:European_Medicines_Agency_(EMA)
gptkb:Food_and_Drug_Administration_(FDA) |